Insights into Hepatocellular Carcinoma: From Pathophysiology to Novel Therapies

Int J Mol Sci. 2024 Apr 10;25(8):4188. doi: 10.3390/ijms25084188.

Abstract

Hepatocellular carcinoma (HCC), the most common primary liver cancer, accounts for 830,180 related deaths worldwide in 2020, according to GLOBOCAN, representing the fourth leading cause of cancer-related death, with a five-year survival rate of about 18% for advanced stage, and the second leading cause in men of cancer-related mortality worldwide [...].

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / therapy

Grants and funding

This research received no external funding.